Terns Pharmaceuticals Inc

Terns Pharmaceuticals Inc. is navigating market volatility with a strategic focus on developing innovative treatments for liver disease and cancer, positioning the company for continued growth and success.

Terns Pharmaceuticals Inc is a biopharmaceutical company specializing in molecularly-targeted and oral molecule drugs, aiming to tackle challenging diseases like liver disease and cancer with innovative treatments.

Terns Pharmaceuticals Inc’s stock has experienced significant volatility, with a 52-week high of $11.4 USD and a low of $1.865 USD, as the company navigates financial challenges and market expectations in the biopharmaceutical sector.